Dr. Riess on the Long-Term Benefit With Immunotherapy for Lung Cancer

Jonathan Riess, MD, assistant professor of medicine, Division of Hematology and Oncology, UC Davis Comprehensive Cancer Center, discusses the long-term benefit with immunotherapy for patients with lung cancer.

According to Riess, patients with stage IV non